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The palladium (II) bis-chelate Pd (L
1−3)2 and platinum (II) tetranuclear Pt4(L
4)4 complexes of benzaldehyde thiosemicarbazone
derivatives have been synthesized, and characterized by elemental analysis and IR, FAB(+)-mass and NMR (1H,13 C) spectroscopy.
The complex Pd(L
2)2 [HL
2 = m-CN-benzaldehyde thiosemicarbazone] shows a square-planar geometry with two deprotonated
ligands(L)coordinatedtoPd
II throughthenitrogenandsulphuratomsinatransarrangement,whilethecomplexPt4(L
4)4 [HL
4 =
4-phenyl-1-benzaldehyde thiosemicarbazone] has a tetranuclear geometry with four tridentate ligands coordinated to four Pt
II
ions through the carbon (aromatic ring), nitrogen, and sulphur atoms where the ligands are deprotonated at the NH group. The
in vitro antitumor activity of the ligands and their complexes was determined against diﬀerent human tumor cell lines, which
revealed that the palladium (II) and platinum (II) complexes are more cytotoxic than their ligands with IC50 values at the range
of 0.07–3.67μM. The tetranuclear complex Pt4(L
4)4, with the phenyl group in the terminal amine of the ligand, showed higher
antiproliferative activity (CI50 = 0.07–0.12μM) than the other tested palladium (II) complexes.
Copyright © 2008 Wilfredo Hern´ andeza et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
The synthesis of transition metal complexes with thiosemi-
carbazone ligands has been receiving considerable attention
due to the pharmacological properties of both ligands and
complexes [1–3]. Thiosemicarbazone derivatives exhibit a
great variety of biological activities, such as antitumor [4],
antifungal [5, 6], antibacterial [6, 7], and antiviral [8]
properties.
The deprotonated thiosemicarbazone ligands usually
coordinate to platinum, palladium, copper, ruthenium, and
osmiumthroughoxygen,nitrogen,andsulphurdonoratoms
in their (N, S) bidentate form or (N, N, S or O, N, S)
tridentate form, to form metallic complexes of diﬀerent
molecular geometry [9–11].
The square planar platinum (II) and palladium (II)
complexes of M(HL)Cl2 and M(L)Cl type with thiosemi-
carbazone ligands derived from phenylacetaldehyde and 2-
formylpyridine showed high cytotoxicity in vitro against
HL60 leukemia and P388 mouse leukemia cell lines [12],
while platinum(II) and palladium(II) binuclear complexes
with p-isopropylbenzaldehyde thiosemicarbazone ligands
exhibit strong cytotoxic activities on mouse tumor cell
growth inhibition [4, 13].
On the other hand, C,N,S thiosemicarbazone ligands can
alsobecoordinatedtopalladium(II)toformcomplexeswith2 Bioinorganic Chemistry and Applications
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Scheme 1: Synthesis of the benzaldehyde thiosemicarbazone and 4-phenyl-1-benzaldehyde thiosemicarbazone ligands.
two fused ﬁve-membered chelate rings containing a carbon-
metalσ bond[14].Althoughthereislittleinformationabout
the antitumor activity of these tetranuclear complexes, their
pharmacological applications could be relevant.
As part of our continuing investigations about metal
complexes with ligands derived from thiourea [15–19]
such as thiosemicarbazones, we report here the synthesis,
characterization, and antitumor activity of palladium(II)
bis-chelates Pd(L1–3)2 and platinum (II) tetranuclear com-
plex Pt4(L4)4 with benzaldehyde thiosemicarbazone and
4-phenyl-1-benzaldehyde thiosemicarbazone ligands, R-
PhCH=N-NH-C(=S)-NHR1,HL 1(R,R1=H),HL2(R=m-CN,
R1=H), HL3(R=o-NO2,R 1=H), and HL4(R=H, R1=Ph).
2. EXPERIMENTAL
2.1. Materialsandmeasurements
Chemicals were reagent grade. Palladium (II) bis(acety-
lacetonate), ammonium tetrachloroplatinate, thiosemicar-
bazide, 4-phenyl-thiosemicarbazide, benzaldehyde, m-CN-
benzaldehyde, and o-NO2-benzaldehyde were purchased
from Aldrich. Melting points were determined on a B¨ uchi
melting point B-545 apparatus. Elemental analyses were
determined on a Fisons-Carlo Erba Elemental Microan-
alyzer. The infrared (IR) spectra were recorded in solid
state (KBr pellets) on a Bruker FT-IR IFS 55 Equinox
spectrophotometerinthe4000–400cm−1 range.TheFAB(+)
mass spectra were recorded on a ZAB-HSQ (V.G. Analytical
Ltd. Floats Roads, Wythenshawe, Manchester, England)
spectrometer, using 3-nitrobenzyl alcohol as the matrix.
The 1H (300MHz) and 13C (75.5MHz) NMR spectra were
recorded on a Bruker Advance DRX 300 spectrometer at
300K, using DMSO-d6 as solvent. The chemical shifts (δ)i n
ppm were measured relative to tetramethylsilane (TMS).
2.2. Synthesisoftheligands
The thiosemicarbazone derivatives (HL) were prepared
according to the literature [20] as shown in Scheme 1.
Generalmethod
To a hot solution of thiosemicarbazide (1.82g, 20mmol)
or 4-phenylthiosemicarbazide (3.3g, 20mmol ) in 160mL,
methanol was added dropwise a solution of the correspond-
ing benzaldehyde (20mmol) in 70mL methanol during 30
minutes. The mixture was stirred and reﬂuxed for 4 hours,
it was ﬁltered and the ﬁltrate was concentrated to half the
volume under reduced pressure. After a slow evaporation of
the concentrate at room temperature, crystals were collected
by ﬁltration, washed with cold ethanol, and dried in vacuo.
For ligand HL4, the ﬁltrate was kept in the refrigerator and
after several hours small rectangular crystals were obtained.
These crystals were suitable for structure analysis by X-ray
diﬀraction.
2.2.1. Benzaldehydethiosemicarbazone(HL1)
Colorless crystals. Yield 80%, m.p. 167–169
◦C. Anal. Calc.
For C8H9N3S (179,2g/mol): C, 53.6%; H, 5.1%; N, 23.4%;
S, 17.9%. Found: C, 53.5%; H, 5.3%; N, 23.5%; S, 17.7%.
FAB(+)-MS: m/z 179 (M+, 70%); IR (KBr, cm−1): ν(NH2)
3400, 3380; ν(NH) 3250; ν(C=N) 1600; ν(C=S) 885.1H-
NMR (DMSO-d6): δ 7.78 (d, 2Hortho, Ph, J=6.8Hz), 7.39
(t, 2Hmeta, Ph, J= 7.2Hz), 7.40 (t, 1Hpara, Ph, J= 7.2Hz);
8.05 (s, 1H, HC=N); 8.19, 7.98 (d, 2H, NH2); 11.42 (s, 1H,
=N–NH). 13C-NMR (DMSO-d6): δ 128.65, 127.29, 129.83,
134.18 (Ph); 142.28 (HC=N); 178.0 (C=S).
2.2.2. m-cyanobenzaldehydethiosemicarbazone(HL2)
Colorless crystals. Yield 76%, m.p. 203-204
◦C. Anal. Calc.
For C9H8N4S (204,3g/mol): C, 52.9%; H, 3.9%; N, 27.4%;
S, 15.7%. Found: C, 52.8%; H, 3.7%; N, 27.6%; S, 15.5%.;
FAB(+)-MS:m/z205(MH+,100%);IR(KBr,cm−1):ν(NH2)
3410, 3397; ν(NH) 3236 ν(CN) 2233; ν(C=N) 1596; ν(C=S)
880. 1H-NMR (DMSO-d6): δ 7.81, 7.79 (s, d, 2Hortho, Ph, J
=5.9Hz); 7.58 (t, 1Hmeta, Ph, J = 7.7Hz); 7.83 (t, 1Hpara, Ph, J
=5.7Hz);8.03(s,1H,HC=N);8.31,8.26(d,2H,NH2);11.60
(s, 1H, =N–NH).13C-NMR (DMSO-d6): δ 129.87, 118.6,
135.69, 132.32, 132.68 (Ph); 111.97 (CN); 139.66 (HC=N);
178.35 (C=S).135.69, 130.15.
2.2.3. o-nitrobenzaldehydethiosemicarbazone(HL3)
Yellow crystals. Yield 90%, m.p. 214-215
◦C. Anal. Calc. For
C8H8O2N4S (224.3g/mol): C, 42.9%; H, 3.6%; N, 24.9%;
S, 14.3%. Found: C, 42.6%; H, 3.5%; N, 24.6%; S, 14.1%.
FAB(+)-MS:m/z226(MH+,100%);IR(KBr,cm−1):ν(NH2)Wilfredo Hern´ andeza et al. 3
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Scheme 2: Synthesis of the palladium (II) bis-chelate complexes and the platinum (II) tetranuclear complex.
3421, 3370; ν(NH) 3240; ν(C=N) 1602; ν(C=S) 890. 1H-
NMR (DMSO-d6): δ 7.58 (d, 1Hortho, Ph, J = 6.9Hz); 8.02,
7.73 (d,d, 2Hmeta, Ph, J = 7.8Hz); 7.61 (t, 1Hpara, Ph, J
=6.7Hz);8.12 (s, 1H, HC=N); 8.45, 8.41 (d, 2H, NH2); 11.73
(s, 1H, =N–NH).13C-NMR (DMSO-d6): δ 124.54, 137.24,
130.36, 133.36, 128.46, 128.33 (Ph); 148.29 (HC=N); 178.49
(C=S).
2.2.4. 4-phenyl-1-benzaldehydethiosemicarbazone(HL4)
Yellow crystals. Yield 75%, m.p. 192–194
◦C. Anal. Calc. For
C14H13N3S (255.3g/mol): C, 65.9%; H, 5.1%; N, 16.5%;
S, 12.5%. Found: C, 65.4%; H, 5.3%; N, 16.7%; S, 12.6%.
FAB(+)-MS: m/z 255 (M+, 48%); IR (KBr, cm−1): ν(NH)
3245; ν(C=N) 1625; ν(C=S) 915. 1H-NMR (DMSO-d6): δ
7.42 (t, 1Hpara, Ph, J = 6.8Hz); 7.43 (t, 2Hmeta, Ph, J =
6.7Hz); 7.91 (d, 2Hortho, Ph, J = 5.3Hz); 7.21 (t, 1Hpara,
NHPh, J = 6.2Hz); 7.37 (t, 2Hmeta, NHPh, J = 6.4Hz); 7.58
(d, 2Hortho, NHPh, J = 5.6Hz); 8.17 (s, 1H, HC=N); 10.11 (s,
1H, NHPh); 11.83 (s, 1H, =N–NH). 13C-NMR (DMSO-d6):
δ 127.6, 128.6, 130.0, 134.0 (Ph); 125.3, 125.9, 128.0, 139.1
(NH-Ph); 142.9 (HC=N); 176.0 (C=S).
2.3. Synthesisofthepalladium(II)andplatinum(II)
complexes(seeScheme2)
A solution of Pd(acac)2 (0.30g, 1.0mmol) in CH2Cl2/
CH3OH (30mL, 2:1 v/v) or a solution of (NH4)2PtCl4
(0.1865g, 0.5mmol) in water/ethanol (2:1, 15mL) was
added dropwise to a stirred solution of the correspond-
ing thiosemicarbazone (2.0mmol) in 60mL of methanol.
Sodium acetate (0.16g, 2mmol) in 3mL of water was then
added. The solution was reﬂuxed for 2 hours and stirred for
24 hours at room temperature. The precipitate was collected
by ﬁltration and dried in vacuo.
2.3.1. Palladium(II)complexofbenzaldehyde
thiosemicarbazone,Pd(L1)2
Yellow solid. Yield 70%, m.p. 204-205
◦C. Anal. Calc. For
C16H16N6S2Pd (462.9g/mol): C, 41.5%; H, 3.5%; N, 18.2%;
S, 13.9%. Found: C, 40.9%; H, 3.6%; N, 18.6%; S, 13.5%.
FAB(+)-MS: m/z 463 (M+, 60%); IR (KBr, cm−1): ν(NH2)
3390, 3367; ν(C=N) 1582; ν(C=S) 805. 1H-NMR (DMSO-
d6): δ 7.49, 7.45, 7.41, 7.39 (m, Ph); 8.13 (s, 2H, HC=N);
8.29, 8.21 (d, 4H, NH2).4 Bioinorganic Chemistry and Applications
2.3.2. Palladium(II)complexofm-cyanobenzaldehyde
thiosemicarbazone,Pd(L2)2
Crystals suitable for X-ray structure determination were
obtainedbyslowlyevaporatingamethanol/dichloromethane
(2:1) solution at room temperature.
Orange crystals. Yield 63%, m.p. > 240
◦C( d e c o m p . ) .
Anal. Calc. for C18H14N8S2Pd·H2O (530.9g/mol): C, 40.7%;
H, 3.0%; N, 21.1%; S, 12.1%; Found: C, 42.0%; H, 2.7%;
N, 21.6%; S, 12.3%. FAB(+)-MS: m/z 513 (M+-H2O, 100%);
IR (KBr, cm−1): ν(NH2) 3405, 3377; ν(CN) 2230; ν(C=N)
1570; ν(C=S) 815. 1H-NMR (DMSO-d6): δ 7.75, 7.65, 7.55
( m ,P h ) ;8 . 0 6( s ,2 H ,H C =N ) ;8 . 6 8( s ,2 H ,N H 2).
2.3.3. Palladium(II)complexofo-nitrobenzaldehyde
thiosemicarbazone,Pd(L3)2
Yellow solid. Yield 61%, m.p. >260
◦C (decomp.). Anal. Calc.
for C16H14O4N8S2Pd (552.9g/mol): C, 34.8%; H, 2.6%; N,
20.3%; S, 11.6%. Found: C, 34.6%; H, 2.5%; N, 20.6%; S,
11.3%. FAB(+)-MS: m/z 553 (M+, 74%); IR (KBr, cm−1):
ν(NH2) 3400, 3350; ν(C=N) 1585; ν(C=S) 820. 1H-NMR
(DMSO-d6): δ 7.85, 7.80, 7.70 (m, Ph); 8.15 (d, 2H, HC=N);
8.44 (s, 2H, NH2).
2.3.4. Platinum(II)tetranuclearcomplex,Pt4(L4)4
Crystals suitable for structure determination by X-ray
diﬀraction were obtained by slowly evaporating an
ethanol/chloroform (2:1) solution at room temperature.
Red crystals. Yield 57%, m.p. 188-189
◦C. Anal. Calc.
For C56H44N12S4Pt4·2C2H5OH (1885.8g/mol): C, 38.2%;
H, 3.0%; N, 8.9%; S, 6.8%. Found: C, 38.0%; H, 3.0%; N,
8.6%;S,6.5%;IR(KBr,cm−1):ν(NHPh)3200;ν(C=N)1590;
ν(C=S) 840. 1H-NMR (DMSO-d6): δ 7.50–7.80 (m, Ph);
7.0–7.4 (m, NHPh); 8.0 (d, 4H, HC=N); 9.15, 9.68 (d, 4H,
NHPh).
2.4. Crystalstructuredeterminations
The data for the crystal structure determinations were
collected on a Siemens CCD smart diﬀractometer (HL4,
Pt4(L4)4) and a Stoe IPDS2 diﬀractometer (Pd(L2)2)( M o K α
radiation, λ = 0.71073 ˚ A, graphite monochromator). The
intensitieswerecorrectedforLorentzandpolarizationeﬀects
and for absorption using SADABS (Pt4(L4)4) and X-RED/X-
SHAPE (Pd(L2)2) .T h es t r u c t u r e sw e r es o l v e db yd i r e c t
methods, which revealed the positions of all nonhydrogen
atoms and reﬁned on F2 by a full matrix least-squares
procedure using anisotropic displacement parameters with
the exception of the solvent molecules in Pt4(L4)4 which
were reﬁned isotropically. The hydrogen atoms for HL4 and
Pd(L2)2 were located from diﬀerent Fourier syntheses and
reﬁned isotropically. For Pt4(L4)4, the hydrogen atoms were
included in calculated positions and reﬁned in riding mode.
All calculations were carried out using the SHELXS-97 and
SHELXL-97 programs [21, 22]. Crystal data collection and
reﬁnement details for the ligand HL4, the palladium (II)
complexPd(L2)2,andtheplatinum(II)tetranuclearcomplex
Pt4(L4)4 are summarized in Table 1.
2.5. Biologicalactivity
2.5.1. Cellculture
The antitumor assays were performed employing the fol-
lowing cell lines: H460 (human lung large cell carci-
noma), ME180 (human cervix epidermoid carcinoma),
M-14 (human amelanotic melanoma), DU145 (human
prostate carcinoma), MCF-7 (human breast adenocar-
cinoma), HT-29 (human colon adenocarcinoma), PC3
(human prostate carcinoma), and K562 (human chronic
myelogenousleukemia).CellsweremaintainedinDulbecco’s
Modiﬁed Eagle’s Medium (DMEM) supplemented with 10%
fetal calf serum and 50μg/mL gentamycin, and grown at
37
◦Ci na5 %C O 2 humidiﬁed environment.
2.5.2. Assessmentofcytotoxicity
Cells were inoculated into 96-well tissue culture plates at
a density of 3000–5000 cells per well and incubated at
37
◦C with their corresponding growth medium for 24 hours
to allow cells to attach. A plate containing each of these
cells was ﬁxed in situ with trichloroacetic acid (TCA) in
order to obtain the cell values at zero time before adding
the test compounds. The rest of the plates containing the
diﬀerent cell lines received serial dilutions of the ligands
and palladium (II) complexes in DMSO to be incubated
at 37
◦C for 48 hours. The assay was terminated by the
addition of cold TCA. The cell numbers in each well was
determined using the sulforhodamine B (SRB) assay [23].
TCA-treated plates were incubated at 4◦Cf o r1h o u ra n d
then the cells were washed ﬁve times with tap water and
driedcompletelyatroomtemperature.Thecellswerestained
for 20 minutes with a solution of 0.4% sulforhodamine
B in 1% acetic acid. At the end of the staining period,
unbound dye was removed by washing four times with 1%
acetic acid until the washing solution became colorless. After
completedrying,bounddyewassolubilizedwith10mMTris
buﬀer (pH 10.5) and the absorbance reads on an automated
plate reader at a wavelength of 550nm. The IC50 value was
deﬁned as the concentration of test sample resulting in a
50% reduction of absorbance as compared with untreated
controls that received a serial dilution of the solvent in which
thetestsamplesweredissolved,andwasdeterminedbylinear
regression analysis.
For K562 cells, which grow in suspension, instead of
ﬁxing and staining with SRB, cells were counted using a
Coulter counter.
3. RESULTS AND DISCUSSION
3.1. IRspectraoftheligandsandtheircomplexes
The infrared absorption bands become very useful for
determining the mode of coordination of the ligands to
metal. In the IR spectra, the broad bands of the –NH group
observed at 3236–3250cm−1 for the ligands disappear inWilfredo Hern´ andeza et al. 5
Table 1: Crystal data and reﬁnement summary.
HL
4 Pd(L
2)2·H2OP t 4(L
4)4·2C2H5OH
Empirical formula C14H13N3SC 18H16N8OPdS2 C60H56N12O2Pt4S4
Formula weight (g/mol) 255.33 530.91 1885.77
Crystal habit, color Yellow plates Orange prisms Red prisms
Crystal system Triclinic Monoclinic Monoclinic
Space group P-1 C2/c P21
a(˚ A) 5.988(1) 20.016(4) 12.708(1)
b(˚ A) 10.285(2) 6.421(1) 13.639(1)
c(˚ A) 11.410(2) 18.511(4) 17.031(1)
α (◦) 68.040(2)
β (◦) 82.514(3) 120.78(3) 94.054(1)
γ (◦) 86.886(2)
Volume ( ˚ A3) 646.1(2) 2044.0(7) 2944.5(3)
Z; F(000) 2; 268 4; 1064 2; 1784
Densitycalc (g/cm3) 1.313 1.725 2.127
Crystal size (mm) 0.44 × 0.20 × 0.04 0.43 × 0.39 × 0.07 0.16 × 0.16 × 0.05
μ(MoKα)(mm−1) 0.235 1.141 9.669
2θ range (◦) 3.8–50.0 6.8–56.2 3.8–59.0
Temperature (K) 220 213 213
Measured reﬂections 3388 9478 19123
Rint 0.0290 0.0635 0.0224
Unique reﬂections 2252 2462 13693
Observed reﬂections (I>2σ(I)) 1939 2012 12253
Reﬁned parameters 215 170 713
wR2 (unique reﬂections) 0.1693 0.0929 0.0774
R1 (observed reﬂections) 0.0618 0.0331 0.0338
Largest diﬀerence peak and hole (e/ ˚ A3) 0.38/−0.31 1.26/−0.88 1.71/−1.14
the complexes spectra, which indicates the deprotonation
of the NH-CS group. The strong bands observed at 1596–
1625cm−1 range in the free ligands have been assigned to
ν(C=N) stretching vibrations [24]. On complexation, these
bands were observed to be shifted to lower frequencies
(1570–1590cm−1), which are in agreement with the wave
numbers for other bischelate complexes [6, 25, 26]. These
results indicate that the imine nitrogen is coordinated to
the metal ion. All ligands showed medium bands in the
880–915cm−1 range ascribed to ν(C=S) vibrations. These
absorption bands shift 65–80cm−1 to lower frequencies on
the coordination of the thiocarbonyl sulfur to palladium (II)
or platinum (II) ion. These results are in agreement with
other thiosemicarbazone complexes [24, 27]. In addition,
the vibrational frequencies of the –NH2 groups remain
unchanged for both the ligands and the complexes. This
evidence indicates the noncoordination of the –NH2 group
to the Pd(II) center.
3.2. NMRspectraoftheligandsandtheircomplexes
In the 1H-NMR spectra of the ligands, the signals of the
=N–NH protons were observed as singlets at δ 11.42–11.83.
These signals disappeared in the 1H-NMR spectra of the
palladium (II) and platinum (II) complexes indicating the
deprotonation of the =N–NH group. The signals of the
HC=N protons which appear as singlets at δ 8.03–8.17 in
the ligands show a shift to downﬁeld in δ 0.03–0.80 after
complexation. This shift indicates the coordination of the
imine nitrogen to the metal center [28]. The signals of
the aromatic protons of the ligands appeared at δ 7.21–
7.91, and the resonance lines found correspond to the
calculated multiplicity. These signals do not suﬀer relevant
changes in the chemical shifts for the palladium (II) and
platinum (II) complexes. The NH2 signal in the ligands
HL1,H L 2,a n dH L 3appears as doublets at δ 7.98–8.45 due
to the nonequivalence of the amine protons. This evidence
is attributed to the restricted rotation around C–N bond
(thiocarbonyl carbon and terminal amine nitrogen) due to
itspartialdoublebondcharacter[14,29].Thepresenceofthe
phenyl group on the terminal amine (NHPh) of the ligand
HL4 producesadownﬁeldchemicalshiftatδ 2.1withrespect
to the NH2 group of the ligand HL1. This reveals that HL4
is slightly less basic than HL1. The resonance signals of the
–NH2 or NHPh groups in the palladium (II) and platinum
(II) complexes do not change, and this evidence indicates
that the amine groups are not coordinated to the metal ion
[14].
In the 13C-NMR spectra, the carbon resonance signals
of the HC=N group appeared at δ 139.66–148.3. The6 Bioinorganic Chemistry and Applications
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results are similar to the chemical shifts found for the lig-
ands benzophenone thiosemicarbazide and phenylpropenal
thiosemicarbazone (both found at δ 141) [30, 31]. The C=S
signals observed at δ 178.5–176.0 are characteristic for this
group, while the aromatic carbons were observed at δ 139.1–
124.5.
3.3. Structuraldata
The molecular structures of HL4,P d ( L 2)2,a n dP t 4(L4)4 are
shown in Figures 1, 2,a n d3, respectively, whereas their
selected bond lengths and bond angles are presented in
Tables 2 and 3.
Table 2: Selected bond lengths (˚ A) for the HL
4 ligand and the
Pd(L
2)2 and Pt4(L
4)4 complexes.
HL
4 Pd(L
2)2 Pt4(L
4)4
S1–C1 1.686(3) 1.746(2) 1.812(9)
N1–N2 1.378(4) 1.378(2) 1.389(10)
N1–C8 1.284(4) 1.293(11)
N2–C1 1.354(4) 1.296(11)
N3–C1 1.342(4) 1.348(3) 1.354(11)
N3–C2 1.422(4) 1.427(12)
C2–C3 1.472(3)
C8–C9 1.457(4) 1.441(13)
N1–C1 1.316(3)
N2–C2 1.306(3)
Pd1–S1 2.297(1)
Pd1–N2 2.049(2)
Pt–S (intraligand) 2.351(2)
Pt–S
 (bridging) 2.298(2)
Pt–N1 1.991(7)
Pt–C10 2.015(8)
Table 3:Selectedbondangles(◦)fortheHL
4 ligandandthePd(L
2)2
and Pt4(L
4)4 complexes.
HL
4 Pd(L
2)2 Pt4(L
4)4
N2–N1–C8 115.0(3) 118.5(7)
N1–N2–C1 119.8(3) 113.4(7)
C1–N3–C2 127.7(3) 127.6(8)
S1–C1–N2 118.7(2) 124.8(7)
S1–C1–N3 126.1(2) 117.4(2) 114.4(7)
N2–C1–N3 115.2(3) 120.7(8)
N1–C8–C9 121.8(3) 115.0(8)
N2–N1–C1 113.5(2)
N1–N2–C2 116.5(2)
S1–C1–N1 125.3(2)
N1–C1–N3 117.3(2)
N2–C2–C3 131.6(2)
S1–Pd1–N2 82.8(1)
S–Pt–N1 83.1(2)
N1–Pt–C10 80.9(3)
C10–Pt-S
  94.8(3)
S–Pt–S
  101.5(1)
Pt–S1–S1 93.6(3)
Pt–N1–N2 124.2(5)
Pt–N1–C8 117.2(6)
3.3.1. 4-phenyl-1-benzaldehydethiosemicarbazoneHL4
The reaction product of benzaldehyde and 4-phenyl
thiosemicarbazide shows the expected bond lengths, espe-
cially the N1–C8 double bond with a length of 1.284(4) ˚ A
(see Figure 1). The molecular fragment N3-C1(S1)-N2-N1-
C8 is nearly planar. The C9–C14 phenyl ring deviates only
slightly from this mean plane and forms an angle of 56.4(1)
◦
with the C2–C7 phenyl ring.Wilfredo Hern´ andeza et al. 7
There are two hydrogen bonds: an intramolecular N3–
H···N1 [N3–H 0.85 ˚ A, H···N1 2.17 ˚ A, N3···N1
2.615 ˚ A, N3–H···N1 112
◦] hydrogen bond and an inter-
molecular N2–H···S1 [N2–H 0.88 ˚ A, H···S1 2.62 ˚ A,
N2···S1 3.466 ˚ A, N2–H···S1 162
◦] hydrogen bond. The
latter leads to the formation of pairs of molecules in the
crystal structure.
3.3.2. Bis(3-cyanophenyl-1-benzaldehyde
thiosemicarbazonato)palladium(II)Pd(L2)2
3-cyanophenyl-1-benzaldehyde thiosemicarbazone reacts
withpalladium(II)acetylacetonatetoformabis-chelatewith
Ci molecular symmetry (see Figure 2). The deprotonated
ligand coordinates bidentately through S and N. The
coordination of the Pd atom is square planar with a
transarrangement of the coordinating atoms. It leads to a
lengthening of the S1–C1 bond and a shortening of the
N1–C1 bond. The Pd1S1N1N2C1 chelate ring is nearly
planar and forms an angle of 11.5(1)
◦ with the C3–C8
phenyl ring.
In the crystal structure, one molecule of water per
formula unit of the chelate is included.
There are three hydrogen bonds comprising the atom O1
of the water molecule and the atom N4 of the cyano group:
O1–H···S1 [O1–H 0.79 ˚ A, H···S1 2.65 ˚ A, O1···S1
3.418 ˚ A, O1–H···S1 166
◦], N3–H···O1 [N3–H 0.87 ˚ A,
H···O1 2.21 ˚ A, N3···O1 3.081 ˚ A, N3–H···O1
173
◦] and N3–H
  ···N4 [N3–H
  0.85 ˚ A, H
  ···N4
2.22 ˚ A, N3···N4 3.054 ˚ A, N3–H
  ···N4 167
◦].
3.3.3. Tetrakis(4-phenyl-1-benzaldehyde
thiosemicarbazonato)tetraplatinum(II)Pt4(L4)4
4-phenyl-1-benzaldehyde thiosemicarbazone reacts with
ammonium tetrachloroplatinate (II) to form a tetranuclear
complex with slightly distorted square planar geometry (see
Figure 3). The tridentate ligands are deprotonated at the NH
group and coordinated through S, N, and C (aromatic ring).
The fourth coordination site at each Pt atom is occupied
by a sulfur atom of a neighboring ligand. In this way, a
puckered eight-membered ring of alternating Pt and S atoms
is formed as the core of the molecule. Each of the four Pt
atoms belongs to two fused ﬁve-membered chelate rings: the
C, N metallocycle and the N, S chelate moiety.
The Pt-Pt distances range from 3.43 ˚ At o3 . 8 4˚ A. The Pt–
S bonds form two distinct groups with signiﬁcantly diﬀering
lengths: Pt-Schelating 2.351(2) ˚ A and Pt-Sbridging 2.298(2) ˚ A
(mean values). The coordination of the ligand to the Pt
atoms leads to a lengthening of the S–C1 bond (increased
single-bond character) and a shortening of the neighboring
N2–C1 bond (increased double-bond character) compared
with the free ligand.
In the crystal structure, two molecules of ethanol per
formulaunitofthetetranuclearcomplexareincluded,which
stabilizethecrystalstructurebyhydrogenbonds.TheO1and
O2 atoms of the ethanol molecules are bonded by hydrogen
bonds to N3 atoms: N3–H···O1 [N3–H 0.86 ˚ A, H···O1
C9
C8
N1
N2
N3
C1
C10
C11 C12 C13
C14
C2
C7
C6 C5
C4
C3
S1
S2
Pt1
Pt4
Pt2
Pt3
S3
S4
Figure 3: Molecular structure of Pt4(L
4)4.
2.07 ˚ A, N3···O1 2.898 ˚ A, N3–H···O1 162
◦]a n dN 3 –
H
  ···O2 [N3–H
  0.86 ˚ A, H
  ···O2 2.14 ˚ A, N3···O2
2.999 ˚ A, N3–H
  ···O2 173
◦].
The formation of tetranuclear compounds was previ-
ously observed for Pd complexes with similar thiosemicar-
bazone ligands [14].
3.4. Antitumorevaluation
All ligands had a 50% inhibitory concentration (IC50) >
40μM against the used human tumor cell lines. As shown
in Table 4, the palladium (II) and platinum (II) complexes
were more cytotoxic (IC50 = 0.08–12.46μM) than their
respective ligands. These results reveal that the cytotoxic
activity increases dramatically when ligands are coordinated
to the metal ion [18, 19, 32].
The Pd(L2)2 complex with a cyano group in the
metaposition of the aromatic ring and the Pt4(L4)4 tetranu-
clear complex with the phenyl group in the terminal amine
of the ligand showed to be more cytotoxic (IC50 = 0.45–3.67
and 0.07–0.12μM, resp.) than the other Pd(L1)2 and Pd(L3)2
complexes against all tested human tumor cell lines. These
results indicate that the cytotoxic activity is enhanced when
four ligands are coordinated to four platinum atoms.
Probably, the high cytotoxicity of the Pd(L2)2 and
Pt4(L4)4 complexes may be related to the intercalation of
each metal complex between nitrogen bases of the DNA
tumor cells, causing greater conformational changes in the
double helix of DNA and then producing cell death [33, 34].
On the other hand, the Pt4(L4)4 tetranuclear complex
was more cytotoxic (IC50 = 0.08μM) compared with the
cytotoxic activity shown by cisplatin (IC50 = 7.0μM) assayed
in (HL60) human leukemia cells [12]. With respect to8 Bioinorganic Chemistry and Applications
Table 4:IC50(μM)valuesofthepalladiumcomplexes,Pd(1–3)2,andtheplatinumtetranuclearcomplex,Pt4(L
4)4,againstthediﬀerenthuman
tumor cell lines.
Human tumor cell lines Pd(L
1)2 Pd(L
2)2 Pd(L
3)2 Pt4(L
4)4
Lung large cell carcinoma (H460) 8.73 3.53 5.82 0.09
Cervix epidermoid carcinoma (ME180) 10.47 3.67 8.06 0.12
Prostate carcinoma (DU145) 11.59 1.99 9.30 0.10
Breast adenocarcinoma (MCF-7) 8.18 2.09 6.14 0.08
Amelanotic melanoma (M-14) 12.46 1.87 8.74 0.11
Colon adenocarcinoma (HT-29) 7.45 1.35 5.96 0.07
Prostate carcinoma (PC-3) 10.20 1.56 7.36 0.08
Chronic myelogenous leukemia (K562) 6.15 0.45 3.04 0.08
(a)Cl50 corresponds to the concentration required to inhibit a 50% of the cell growth when the cells are exposed to the compounds during 48 hours. Each
value is the average of two independent experiments.
the cytotoxicity shown by the square planar copper (II)
complexes with carboxamidrazone ligands (IC50 = 3.0μM),
assayed in vitro against to the (MCF-7) human breast adeno-
carcinoma cell line [35], the Pt4(L4)4 complex resulted to be
more cytotoxic, while the Pd(L2)2 complex showed a similar
inhibition concentration (IC50 = 2.09μM). In relation to
other palladium (II) and platinum (II) complexes of the
M(HL)Cl2 typewithphenylacetaldehydethiosemicarbazone
ligands (IC50 = 38 and 9μM, resp.) assayed in the K562
human chronic myelogenous leukemia cell line [12], the
Pd(L2)2 and Pt4(L4)4 complexes showed higher cytotoxic
activity. In addition, the Pd(L2)2 complex resulted to be
more cytotoxic (IC50 = 2.09μM) than the palladium (II) and
copper (II) complexes of the M(L)Cl type (IC50 = 12.94 and
3.98, resp.) and the NiL2 complex (IC50 = 2.25μM) with
1,2-naphthoquinone-1-thiosemicarbazone ligands, tested in
vitro against to the MCF-7 human breast adenocarcinoma
cell line [34].
I ns u m m a r y ,w eh a v ep r e p a r e dt h ep a l l a d i u m( I I )
bis-chelate complexes and the platinum (II) tetranuclear
complex,Pd(L1–3)2,andPt 4(L4)4,whichweremorecytotoxic
on all the human tumor cell lines at low micromolar
concentrations with respect to the free ligands. The crystal
structure of Pd(L2)2 shows that the palladium atom has a
square-planar geometry with two bidentate ligands having
sulfur and nitrogen as donor atoms in transpositions. The
complex Pt4(L4)4 has a tetranuclear structure with four
tridentate(C,N,S) ligands coordinated to four platinum
atoms.
Supplementarymaterial
Further details of the crystal structure determination are
available on request from the Cambridge Crystallographic
Data Center (CCDC, 12 Union Road, Cambidge CB2 1EZ,
UK; fax: +44 1223 336033; email: deposit@ccdc.cam.ac.uk),
on quoting the depositing numbers CCDC 694972 for HL4,
694973 for Pd(L2)2, and 694974 for Pt4(L4)4, the names of
the authors, and the journal citation.
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